Financial Wire

Mineral Resources Prices $1.3 Billion in Senior Unsecured Notes to Refinance Existing Debt

-- Mineral Resources (ASX:MIN) said it has priced $650 million in 6% senior unsecured notes due May 2032 and $650 million in 6.25% senior unsecured notes due May 2034, in an offering to qualified institutional buyers, according to a Tuesday Australian bourse filing.

The company said the settlement is expected to occur in New York on April 29, with interest payable on May 1 and Nov. 1 each year, and the notes are guaranteed by its certain units.

The company will use the proceeds, together with cash on hand, to refinance its existing $625 million 8% senior unsecured notes due November 2027, fully repay the outstanding balance of its iron ore prepayment, and redeem $350 million of its existing $1.1 billion 9.25% senior unsecured notes due October 2028.

The transaction is expected to deliver finance cost savings of AU$48 million per year, decreasing the company's weighted average cost of debt to 7.4% from 8.4% and extending its weighted average tenor to five years from 3.1 years, the filing added.

Related Articles

Asia

Wasion to Raise HK$1.5 Billion via Share Placement, Top-Up Subscription

Wasion Holdings (HKG:3393) plans to raise about HK$1.47 billion in net proceeds through a share placing and top-up subscription, according to a Tuesday Hong Kong bourse filing.Shareholder Star Treasure Investments will place up to 50 million shares at HK$30.00 each to at least six investors on a best-efforts basis.The placing represents about 5% of the company's existing issued share capital.Wasion will issue the same number of new shares to the seller under a top-up subscription at the same price.Net proceeds will be used for business expansion, research and development, overseas market growth, potential acquisitions, debt repayment, and general working capital.

$HKG:3393
Asia

Recce Pharmaceuticals Says Indonesian Regulator Completes Routine Regulatory Inspection of Phase Three Clinical Trial Site

Recce Pharmaceuticals (ASX:RCE) said the Indonesian National Agency of Drug and Food Control completed a comprehensive routine regulatory inspection of a phase three clinical trial site in Indonesia, with no findings noted that prevent the study from continuing, according to a Tuesday Australian bourse filing.The phase three clinical trial for the treatment of diabetic foot infections is advancing patient dosing, and it is on track to produce interim data from 155 patients.The firm's shares rose 2% in recent trading on Tuesday.

$ASX:RCE
Asia

ASX Midday Sector Update: Consumer Staples Gain, Energy Stocks Slide

Consumer staples stocks were advancing about 0.5% in midday trading Tuesday, posting a very thin lead over gains for information technology shares.Woolworths Group (ASX:WOW) was up nearly 1% and Coles Group (ASX:COL) rose less than 1%.On the flip side, energy stocks were down 1% as oil prices trended lower amid hopes that Iran will join a second round of peace negotiations with the US.Woodside Energy Group (ASX:WDS) was shedding almost 2%, while Santos (ASX:STO) was down more than 1%.

$^AXJO$ASX:COL$ASX:STO$ASX:WDS$ASX:WOW